Tate & Lyle PLC
24 September 2003 - Tate & Lyle PLC
Trading Update
In line with its regular practice, Tate & Lyle issues the following trading
update prior to meeting with stockbrokers' analysts and entering its closed
period for interim results to 30 September 2003. The interim results will be
announced on 6 November 2003.
Based upon the results for the five months to August 2003, profit before tax and
exceptional items has been in line with internal expectations we set at the
beginning of the financial year. Our major business units have all traded at or
around plan levels.
Results from the citric acid production line have improved following the
acceleration of the closure of the Mexican plant in July 2003 and a small
increase in spot selling prices. Trading in the last three months has been at
the break-even level.
The actuarial review of the UK pension fund at 31 March 2003 has not yet been
finalised but it is anticipated that there will be a small deficit which will
result in a modest additional charge to profit.
The dry weather in Europe has resulted in both wheat and maize price increases
in Europe the effect of which we intend to mitigate with selling price increases
in the second half.
The first half last year benefited from strong trading and unusual interest
income. As indicated in the announcement of the results for the year to March
2003, we expect a more even split of profits in the current financial year with
the first half weaker and the second half stronger than in the previous year.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.